Welcome to Unmute MS – An educational podcast series developed by Novartis Pharmaceuticals UK Ltd.

Uncover the biggest questions in multiple sclerosis (MS) and join the conversation that’s shaping the future for patients and clinicians.

Developed for UK healthcare professionals to listen to on-demand, this series of podcasts unpicks the latest insights and current thinking around the questions you most want unmuted in MS.

Image of Dr Nikos Evangelou

Dr Nikos Evangelou – Clinical Associate Professor in Neurology
University of Nottingham

  • The relationship between cognition and MS
  • What is the best way to measure cognition for MS patients?
Image of Abhijit Chaudhuri consultant neurologist

Dr Abhijit Chaudhuri – Consultant Neurologist
Queen’s Hospital in Romford

  • Clinical insights into the diagnosis pathways for MS – how important is an early diagnosis?
  • The evolution of MS treatments – a case for early and efficacious treatment
Image of Mark Webb

Mark Webb – MS advocate and a patient with MS

  • My journey to an MS diagnosis and beyond
  • Signals of MS progression from a patient’s perspective
Image of Dr Agne Straukiene

Dr Agne Straukiene – Consultant Neurologist
Torbay and South Devon NHS Foundation Trust

  • What part does technology have to play in the future of MS healthcare?
  • How vital is the role of health and wellbeing to patient outcomes in MS?
Image of Dr David Rog

Dr David Rog – Consultant Neurologist
Salford Royal NHS Foundation Trust

  • COVID-19 and MS: a once-in-a-generation opportunity to instigate change?
Image of Dr Wallace Brownlee

Dr Wallace Brownlee – MS Specialist Neurologist
National Hospital for Neurology and Neurosurgery, Queen Square

  • Diagnosing and defining Secondary Progressive MS – when is the time right?
  • Managing people with SPMS – what does the future hold?
Image of Dr Ronan Burke

Dr Ronan Burke – Clinical Psychologist
National Hospital for Neurology and Neurosurgery, Queen Square

  • Opening the mental health conversation – how do psychologists support people with MS?
  • How can MS services best support patients’ mental health?
Image of Professor Paul Matthews

Professor Paul Matthews – Head of Department of Brain Sciences
Imperial College London

  • What can imaging tell us about MS pathology?
  • How does imaging impact clinical practice? Predicting, monitoring and progression.

Click below with Apple Podcasts installed to subscribe.


Alternatively, to subscribe manually, please navigate to ‘add show by URL’ in your podcast app, and paste in the URL:



You can also listen to the Unmute MS here:

Unmute MS was created and funded by Novartis Pharmaceuticals UK Ltd and is intended for UK healthcare professionals.

MS, multiple sclerosis; SPMS, secondary progressive multiple sclerosis.

Rate this content: 
Average: 4.6 (9 votes)
UK | July 2022 | 212459

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]